188 related articles for article (PubMed ID: 38589923)
1. MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus.
Wang T; Song D; Li X; Luo Y; Yang D; Liu X; Kong X; Xing Y; Bi S; Zhang Y; Hu T; Zhang Y; Dai S; Shao Z; Chen D; Hou J; Ballestar E; Cai J; Zheng F; Yang JY
Cell Commun Signal; 2024 Apr; 22(1):220. PubMed ID: 38589923
[TBL] [Abstract][Full Text] [Related]
2. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
Front Immunol; 2019; 10():1546. PubMed ID: 31354711
[TBL] [Abstract][Full Text] [Related]
3. Lupus Autoimmunity and Metabolic Parameters Are Exacerbated Upon High Fat Diet-Induced Obesity Due to TLR7 Signaling.
Hanna Kazazian N; Wang Y; Roussel-Queval A; Marcadet L; Chasson L; Laprie C; Desnues B; Charaix J; Irla M; Alexopoulou L
Front Immunol; 2019; 10():2015. PubMed ID: 31552019
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.
Tran NL; Manzin-Lorenzi C; Santiago-Raber ML
Immunology; 2015 May; 145(1):60-70. PubMed ID: 25424423
[TBL] [Abstract][Full Text] [Related]
5. Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.
Gysler SM; Mulla MJ; Guerra M; Brosens JJ; Salmon JE; Chamley LW; Abrahams VM
Mol Hum Reprod; 2016 Jul; 22(7):465-74. PubMed ID: 27029214
[TBL] [Abstract][Full Text] [Related]
6. TLR7 Mediates Acute Respiratory Distress Syndrome in Sepsis by Sensing Extracellular miR-146a.
Huang H; Zhu J; Gu L; Hu J; Feng X; Huang W; Wang S; Yang Y; Cui P; Lin SH; Suen A; Shimada BK; Williams B; Kane MA; Ke Y; Zhang CO; Birukova AA; Birukov KG; Chao W; Zou L
Am J Respir Cell Mol Biol; 2022 Sep; 67(3):375-388. PubMed ID: 35679261
[TBL] [Abstract][Full Text] [Related]
7. A novel Toll-like receptor 7/8-specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus.
Ishizaka ST; Hawkins L; Chen Q; Tago F; Yagi T; Sakaniwa K; Zhang Z; Shimizu T; Shirato M
Eur J Pharmacol; 2023 Oct; 957():175962. PubMed ID: 37544422
[TBL] [Abstract][Full Text] [Related]
8. Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus.
von Hofsten S; Fenton KA; Pedersen HL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791389
[TBL] [Abstract][Full Text] [Related]
9. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.
Umiker BR; Andersson S; Fernandez L; Korgaokar P; Larbi A; Pilichowska M; Weinkauf CC; Wortis HH; Kearney JF; Imanishi-Kari T
Eur J Immunol; 2014 May; 44(5):1503-16. PubMed ID: 24500834
[TBL] [Abstract][Full Text] [Related]
10. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA miR-181d-5p regulates the MAPK signaling pathway by targeting mitogen-activated protein kinase 8 (MAPK8) to improve lupus nephritis.
Chai F; Peng H; Qin L; Liu C; Zeng Y; Wang R; Xu G; Wang R; Wei G; Huang H; Lan Y; Chen W; Wang C
Gene; 2024 Jan; 893():147961. PubMed ID: 37931853
[TBL] [Abstract][Full Text] [Related]
12. Circulating Plasma Extracellular Vesicles from Septic Mice Induce Inflammation via MicroRNA- and TLR7-Dependent Mechanisms.
Xu J; Feng Y; Jeyaram A; Jay SM; Zou L; Chao W
J Immunol; 2018 Dec; 201(11):3392-3400. PubMed ID: 30355788
[TBL] [Abstract][Full Text] [Related]
13. Anti-TLR7 Antibody Protects Against Lupus Nephritis in NZBWF1 Mice by Targeting B Cells and Patrolling Monocytes.
Murakami Y; Fukui R; Tanaka R; Motoi Y; Kanno A; Sato R; Yamaguchi K; Amano H; Furukawa Y; Suzuki H; Suzuki Y; Tamura N; Yamashita N; Miyake K
Front Immunol; 2021; 12():777197. PubMed ID: 34868046
[TBL] [Abstract][Full Text] [Related]
14. Humanized TLR7/8 expression drives proliferative multisystemic histiocytosis in C57BL/6 mice.
Snyder JM; Treuting PM; Nagy L; Yam C; Yi J; Brasfield A; Nguyen LP; Hajjar AM
PLoS One; 2014; 9(9):e107257. PubMed ID: 25229618
[TBL] [Abstract][Full Text] [Related]
15. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
16. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice.
Desnues B; Macedo AB; Roussel-Queval A; Bonnardel J; Henri S; Demaria O; Alexopoulou L
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1497-502. PubMed ID: 24474776
[TBL] [Abstract][Full Text] [Related]
17. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
18. CD8 T Cell-Derived Exosomal miR-186-5p Elicits Renal Inflammation via Activating Tubular TLR7/8 Signal Axis.
Xu X; Qu S; Zhang C; Zhang M; Qin W; Ren G; Bao H; Li L; Zen K; Liu Z
Adv Sci (Weinh); 2023 Sep; 10(25):e2301492. PubMed ID: 37395441
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration.
Wallach T; Mossmann ZJ; Szczepek M; Wetzel M; Machado R; Raden M; Miladi M; Kleinau G; Krüger C; Dembny P; Adler D; Zhai Y; Kumbol V; Dzaye O; Schüler J; Futschik M; Backofen R; Scheerer P; Lehnardt S
Mol Neurodegener; 2021 Nov; 16(1):80. PubMed ID: 34838071
[TBL] [Abstract][Full Text] [Related]
20. Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.
Hayakawa K; Fujishiro M; Yoshida Y; Kataoka Y; Sakuma S; Nishi T; Ikeda K; Morimoto S; Takamori K; Sekigawa I
Clin Exp Immunol; 2022 May; 208(1):33-46. PubMed ID: 35260898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]